---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-23-000010"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2023-01-27T23:59:59+00:00"
generated_at: "2026-06-20T07:23:14.718445+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics receives Nasdaq notice for non-compliance with minimum bid price rule

## Summary
- Received Nasdaq deficiency notice on Jan 24, 2023, for bid price below $1.00 for 30 consecutive business days.
- No immediate effect on listing or trading; 180-day compliance period ends July 24, 2023.
- Can regain compliance if bid price closes at $1.00+ for 10 consecutive business days before deadline.
- Company monitoring bid price and evaluating options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001842952-23-000010
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2023-01-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000010/0001842952-23-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000010/cntx-20230124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-23-000010
- JSON: https://secwatch.observer/filing/0001842952-23-000010.json
- Plain text: https://secwatch.observer/filing/0001842952-23-000010.txt

## Key facts
- Listing & Compliance Notices
  Context Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: January 24, 2023, Context Therapeutics Inc. (the “Company”) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Notification Letter has no immediate effect on the Nasdaq listing or trading of the Company’s common stock. The Notification Letter provides an initial 180 calendar day period, or until July
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000010/0001842952-23-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.